Yahoo Web Search

Search results

  1. Jun 13, 2024 · Alberto Pugliese, MD, has the following relevant financial relationships: Consultant or advisor for: Quell Therapeutics (former); Provention Bio, Inc. (former)

  2. Jun 14, 2024 · Increased glucagon release from alpha cells is the main defense against hypoglycemia, a mechanism lost in Type 1 Diabetes (T1D). We hypothesize that the absence of neighboring beta cells, and consequently the loss of their inhibitory signals, plays a crucial role in the impaired responsiveness of alpha cells to hypoglycemic conditions.

  3. Jun 24, 2024 · Julia Panzer, Ph.D., a staff scientist in the lab of Alberto Pugliese, M.D., City of Hope’s Samuel Rahbar Chair in Diabetes & Drug Discovery, chair of the Department of Diabetes Immunology and...

  4. Jun 24, 2024 · Julia Panzer, Ph.D., a staff scientist in the lab of Alberto Pugliese, M.D., City of Hope’s Samuel Rahbar Chair in Diabetes & Drug Discovery, chair of the Department of Diabetes Immunology and...

  5. Jun 13, 2024 · Alberto Pugliese & Karen Cerosaletti. Nature Communications 15, Article number: 4971 ( 2024 ) Cite this article. 923 Accesses. 9 Altmetric. Metrics. Abstract. Human type 1 diabetes (T1D) is...

    • Peter S. Linsley
  6. Jun 24, 2024 · Julia Panzer, Ph.D., a staff scientist in the lab of Alberto Pugliese, M.D., City of Hope’s Samuel Rahbar Chair in Diabetes & Drug Discovery, chair of the Department of Diabetes Immunology and...

  7. Jun 24, 2024 · LOS ANGELES-- ( BUSINESS WIRE )-- Researchers with City of Hope®, one of the largest cancer research and treatment organizations in the United States and a leading research center for diabetes and other life-threatening illnesses, presented novel study results at the 84th Scientific Sessions of ADA held June 21 to 24 in Orlando, Florida.